Our group has conducted the first agnostic, exome-wide analyses for PTSD and identified risk variants in genes significantly associated with PTSD diagnosis (MPHOSPH9, LGALS13, and SLC2A2; [26]). The gene discussed is SLC2A2; the disease is post-traumatic stress disorder.